titolo del settore pharma decisamente interessante. 2 prodotti antiumorali al terzo step di approvazione, classica fase di accumulazione quindi da monitorar emolto bene
Luca Proietti.
WWW.OROSAM.IT
WWW.OROSAM.IT
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Luca Proietti.
WWW.OROSAM.IT
WWW.OROSAM.IT
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.